Suurbritannia - inglise - MHRA (Medicines & Healthcare Products Regulatory Agency)

janssen-cilag ltd - darunavir ethanolate - tablet - 75mg

Suurbritannia - inglise - MHRA (Medicines & Healthcare Products Regulatory Agency)

janssen-cilag ltd - darunavir ethanolate - tablet - 150mg

Suurbritannia - inglise - MHRA (Medicines & Healthcare Products Regulatory Agency)

boehringer ingelheim ltd - tipranavir - oral solution - 100mg/1ml

Suurbritannia - inglise - MHRA (Medicines & Healthcare Products Regulatory Agency)

janssen-cilag ltd - cobicistat; emtricitabine; tenofovir alafenamide fumarate; darunavir ethanolate - tablet - 150mg ; 200mg ; 10mg ; 800mg

Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

remedyrepack inc. - efavirenz (unii: je6h2o27p8) (efavirenz - unii:je6h2o27p8) - efavirenz 600 mg - efavirenz in combination with other antiretroviral agents is indicated for the treatment of human immunodeficiency virus type 1 (hiv-1) infection in adults and in pediatric patients at least 3 months old and weighing at least 3.5 kg. - efavirenz tablets are contraindicated in patients with previously demonstrated clinically significant hypersensitivity (e.g., stevens-johnson syndrome, erythema multiforme, or toxic skin eruptions) to any of the components of this product.efavirenz tablets are contraindicated in patients with previously demonstrated clinically significant hypersensitivity (e.g., stevens-johnson syndrome, erythema multiforme, or toxic skin eruptions) to any of the components of this product. - coadministration of efavirenz with elbasvir and grazoprevir is contraindicated [see warnings and precautions (5.1) and drug interactions (7.1) ]. coadministration of efavirenz with elbasvir and grazoprevir is contraindicated [see warnings and precautions (5.1) and drug interactions (7.1) ]. there is a

Iirimaa - inglise - HPRA (Health Products Regulatory Authority)

accord healthcare ireland ltd. - darunavir - film-coated tablet - 600 milligram(s) - protease inhibitors; darunavir

Malta - inglise - Medicines Authority

accord healthcare ireland ltd euro house, euro business park, little island cork, t45 k857, ireland - darunavir propylene, glycolate - film-coated tablet - darunavir propylene glycolate 600 mg - antivirals for systemic use

Austraalia - inglise - Department of Health (Therapeutic Goods Administration)

janssen-cilag pty ltd - tenofovir alafenamide, quantity: 10 mg; darunavir, quantity: 800 mg; cobicistat, quantity: 150 mg; emtricitabine, quantity: 200 mg - tablet, film coated - excipient ingredients: magnesium stearate; croscarmellose sodium; silicon dioxide; microcrystalline cellulose; titanium dioxide; purified talc; iron oxide yellow; polyvinyl alcohol; macrogol 3350 - symtuza is indicated as a complete regimen for the treatment of human immunodeficiency virus type 1 (hiv-1) infection in adults and adolescents (aged 12 years and older with body weight at least 40 kg). genotypic testing should guide the use of symtuza (see section 4.2 dose and method of administration, section 4.4 special warnings and precautions for use and section 5.1 pharmacodynamic properties).

Malaisia - inglise - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

johnson & johnson sdn bhd - darunavir ethanolate; cobicistat on silicon dioxide -

Austraalia - inglise - Department of Health (Therapeutic Goods Administration)

abbvie pty ltd - ritonavir; lopinavir -